Skip to Main Content

Paper Details

Lenalidomide results in a durable complete remission in acute myeloid leukemia accompanied by persistence of somatic mutations and a T-cell infiltrate in the bone marrow.
Haematologica
1
2018
Lenalidomide, T-cell infiltrate, acute myeloid leukemia
Author NameAffiliation
Christopher A MillerMcDonnell Genome Institute, Washington University School of Medicine
John F DiPersioWashington University School of Medicine
Ravi VijWashington University School of Medicine
Sharon E HeathWashington University School of Medicine
Peter WesterveltWashington University School of Medicine
Todd A FehnigerWashington University School of Medicine
  • 1 - 6

Datasets

Release 1.2